Biovail Sues Impax Over Wellbutrin XL Patent
A subsidiary of Canadian drug maker Biovail Corp. has filed a lawsuit against Impax Laboratories Inc. over Impax's plans to launch a generic version of Biovail's antidepressant drug Wellbutrin XL....To view the full article, register now.
Already a subscriber? Click here to view full article